Choate has been shortlisted as a finalist for three LSPN 2026 Life Sciences IP Review Awards, including Life Sciences IP Firm of the Year, Life Sciences IP Litigation Firm of the Year, and Life Sciences Patent Strategy Firm of the Year. LSPN Award nominees are evaluated by a panel of industry experts utilizing a two-stage process to ensure that winners are selected through both objective evaluation and thoughtful peer discussion. The awards will be presented during LSPN’s Spring Conference, taking place April 29-30 in Boston.